CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 142 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36 | -100.0% | 24,136 | -54.0% | 0.00% | -82.6% |
| Q4 2021 | $227,000 | +146.7% | 52,434 | +273.2% | 0.02% | +130.0% |
| Q4 2020 | $92,000 | +5.7% | 14,051 | +7.5% | 0.01% | -33.3% |
| Q3 2020 | $87,000 | -72.5% | 13,065 | +17.5% | 0.02% | -11.8% |
| Q1 2018 | $316,000 | +41.7% | 11,123 | -9.5% | 0.02% | +54.5% |
| Q3 2017 | $223,000 | – | 12,291 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |